Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham — Birmingham, Alabama

Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham has participated in 1 clinical trials.

Therapeutic areas: Pediatric Multiple Sclerosis.

Sponsors: University of California, San Francisco.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham?

Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham conducted?

Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham has 1 clinical trials on record. Their work covers Pediatric Multiple Sclerosis.

Is Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham accredited by Crixeo Health?

Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.